Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Collaboration and Partnerships

Sponsored by

Back to Results


Finalist

HS Online

by AbbVie with support from Biosector 2, a Syneos Health™ Company


Summary of work

Hidradenitis Suppurativa (HS) is chronic skin condition which results in painful lesions, nodules and boils around the armpits and groin. Though it is estimated to impact 1% of the global population, the HS community experiences low diagnosis rates and extraordinary delays in care.

AbbVie created the first ever global campaign to help drive awareness of HS in patients and HCPs so more people receive a timely diagnosis and learn more about how they can best manage their condition. There was so little content available online that we decided our initial approach was to provide educational content (including patient testimonials). In partnership with a patient advocacy group and KOLs AbbVie developed content such as tips on wound care, lifestyle, smoking cessation and weight management; assisting both diagnosed and undiagnosed patients. We also developed an interactive assessment tool to allow people to check whether their symptoms could be HS. Users could take their results, alongside consultation tips, with them to their doctor, enabling them to have a more informed conversation.

HS Online has been localised in 43 countries and, as of June 2018, has reached over 2 million people worldwide.

Judges' comments

A great initiative, demonstrating clear scalability and collaboration with local advocacy groups and opinion leaders.  Impressive SMART objectives that AbbVie delivered against.


Winner

Travel with IBD - by Crohn’s & Colitis UK and Takeda with support from Aurora Healthcare Communications


Highly commended

Hepatitis C Testing in Community Pharmacies: A Ground-Breaking Partnership Pilot Project - by London Joint Working Group on Substance Use and Hepatitis C with support from Principle Consulting and MSD


Finalists

HS Online - by AbbVie with support from Biosector 2, a Syneos Health™ Company

Act on PAH: Improve Patient Outcomes with Early Diagnosis - by Actelion Pharmaceuticals UK Ltd with support from NexGen Healthcare Communications

IBD Registry Industry Working Group - by British Society of Gastroenterology (BSG) with support from Dovetail